Search tool

Displaying 1 - 4 of 4

News

New EMCDDA report underlines need to scale up drug services in prisons

25.06.2021

Current insights and future challenges on drugs and prison in Europe are explored today in a major new study published by the EU drugs agency (EMCDDA)(1). Released on the eve of International day against drug abuse and illicit trafficking, the report, Prison and drugs in Europe: current and future...

News

Preventing blood-borne viruses in prison settings: ECDC and EMCDDA guidance

23.07.2018

People in prison experience a higher burden of communicable diseases such as hepatitis B (HBV), hepatitis C (HCV) and HIV often linked to a history of injecting drug use. In addition, incarceration can result in a higher risk of transmission of communicable diseases, due to factors such as...

News

ECDC and EMCDDA make the case for active case finding of communicable diseases in prison

23.05.2018

What are the most (cost-) effective ways to prevent and control communicable diseases in prison settings? In their joint public health Guidance published today, ECDC and the EMCDDA present the evidence on active case finding as a key measure to diagnose communicable diseases early. The two agencies...

News

ECDC–EMCDDA review: Can active case finding help reduce communicable diseases in prisons?

23.11.2017

Compared with the general public, people in prison have a higher prevalence of infection with HIV, hepatitis B, hepatitis C, syphilis, gonorrhoea, chlamydia and tuberculosis. Such increased prevalence of diseases among people in prisons is recognised as a major risk for the health of both people...
Loading